The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
This is an observational study only for all consented subjects who undergo an Exablate treatment. The Exablate procedure is a commercial treatment. The objective of this registry is to collect data about the effect of Exablate treatment on potential pregnancy occurrences in this population for two years post-treatment for purposes of labeling updates and overall safety data collection.
Study Type
OBSERVATIONAL
Enrollment
200
MR-Guided Focused Ultrasound
UCLA
Los Angeles, California, United States
RECRUITINGStanford University
Stanford, California, United States
RECRUITINGMayo Clinic
Rochester, Minnesota, United States
Occurrence of adverse events
All adverse events and/or serious adverse events will be documented and reported according to protocol.
Time frame: Through study completion, an average of 2 years.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Huashan Hospital Affiliated to Fudan University
Shanghai, China
ACTIVE_NOT_RECRUITINGShanghai No. 1 Hospital
Shanghai, China
RECRUITINGShanghai No.1 Hospital
Shanghai, China
RECRUITING